| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 241 | 132 | +82.2% |
| EBITDA | 39.9 | 15.9 | +151.3% |
| EBITDA margin | 16.6% | 12.0% | +4.6 pts |
| Profit before tax | 39.0 | 14.9 | +162.9% |
| Net profit | 31.1 | 12.1 | +156.7% |
| EPS | ₹2.04 | ₹0.80 | +155.0% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 1,364 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 147 | 147 | 169 | 152 | 78.5 | ||
| 114 | 114 | 109 | 36.9 | 34.1 | ||
| 1,330 | — | — | — | — | ||
| 822 | 713 | 556 | 517 | 582 | ||
| — | +28.3% | +7.5% | −11.1% | — | ||
| 114 | 89.6 | 70.3 | 79.4 | 121 | ||
| 13.8% | 12.6% | 12.7% | 15.3% | 20.8% | ||
| 102 | 78.2 | 56.5 | 65.5 | 108 | ||
| 83.8 | 64.8 | 48.2 | 53.3 | 77.4 | ||
| 10.2% | 9.1% | 8.7% | 10.3% | 13.3% | ||
| ₹5.50 | ₹4.26 | ₹3.17 | ₹3.50 | ₹5.08 | ||
| — | +34.4% | −9.5% | −31.2% | — | ||
| — | 12.0 | −32.5 | 98.5 | 51.2 | ||
| — | −23.4 | −9.2 | −17.6 | −7.9 | ||
| −11.4 | −11.4 | −41.7 | 80.9 | 43.2 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 1,364.0 | |
| - Cash, Equiv & ST Investments | 78.5 | 152.1 | 169.3 | 147.1 | 147.1 | |
| + Total Debt | 34.1 | 36.9 | 109.0 | 113.6 | 113.6 | |
| Enterprise Value | — | — | — | — | 1,330.5 | |
| Revenue | 582.2 | 517.3 | 556.0 | 713.2 | 822.0 | |
| Growth %, YoY | — | -11.1 | +7.5 | +28.3 | — | |
| EBITDA | 120.9 | 79.4 | 70.3 | 89.6 | 113.6 | |
| Margin % | 20.77 | 15.34 | 12.65 | 12.56 | 13.82 | |
| EBIT | 107.5 | 65.5 | 56.5 | 78.2 | 102.0 | |
| Net Income | 77.4 | 53.3 | 48.2 | 64.8 | 83.8 | |
| Margin % | 13.29 | 10.30 | 8.67 | 9.09 | 10.19 | |
| EPS, Adj (current shares) | 5.08 | 3.50 | 3.17 | 4.26 | 5.50 | |
| Growth %, YoY | — | -31.2 | -9.5 | +34.4 | — | |
| Cash from Operations | 51.2 | 98.5 | -32.5 | 12.0 | — | |
| Capital Expenditures | -7.9 | -17.6 | -9.2 | -23.4 | — | |
| Free Cash Flow | 43.2 | 80.9 | -41.7 | -11.4 | -11.4 | |
Prices at the previous close · figures from the company's filings with NSE
AVT Natural Products (NSE: AVTNPL) had a market capitalisation of ₹1,364 crore at the previous close (₹89.57 a share), a PE ratio of 16.3 on the last four quarters' profit and a price-to-book ratio of 2.44. In FY26 its consolidated net profit was ₹64.8 crore on revenue of ₹713 crore; in Q1 FY27 (April–June 2026) it was ₹31.1 crore, up 156.7% year on year. Its debt-to-equity ratio was 0.20 on 31 March 2026. Promoters held 75.00% of the shares on 30 September 2026.
AVT Natural Products' PE ratio is 16.3 at the previous close (₹89.57 a share): a market capitalisation of ₹1,364 crore divided by consolidated net profit of ₹83.8 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹64.8 crore) it is 21.0.
AVT Natural Products' price-to-book (PB) ratio is 2.44 at the previous close: a market capitalisation of ₹1,364 crore divided by shareholders' equity (book value) of ₹559 crore on 31 March 2026. That is a book value of ₹36.73 per share against a share price of ₹89.57.
AVT Natural Products' book value per share was ₹36.73 on 31 March 2026: shareholders' equity of ₹559 crore divided by the 15.23 crore shares in issue, up 10.5% from ₹33.25 a year earlier. The share price at the previous close was ₹89.57.
AVT Natural Products' market capitalisation was ₹1,364 crore at the previous close: 15.23 crore shares at ₹89.57 each.
No. AVT Natural Products had borrowings of ₹114 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.20. Its cash and current investments were ₹151 crore, so it held net cash of ₹37.6 crore.
AVT Natural Products' basic earnings per share (EPS) were ₹4.26 in FY26, against ₹3.17 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹5.50.
AVT Natural Products' debt-to-equity ratio was 0.20 on 31 March 2026: borrowings of ₹114 crore against total equity of ₹559 crore. A year earlier, on 31 March 2025, it was 0.22.
AVT Natural Products' net worth — shareholders' equity in its consolidated balance sheet — was ₹559 crore on 31 March 2026, up 10.5% from ₹506 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,364 crore at the previous close.
In 2026, AVT Natural Products has declared two dividends totalling ₹0.80 a share: ₹0.35 (interim) with record date 19 February 2026 and ex-date 18 February 2026 and ₹0.45 with record date 10 August 2026.
In FY26, AVT Natural Products' return on equity (ROE) was 12.2% and its return on capital employed (ROCE) was 14.4%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 9.9% and ROCE 11.3%.
AVT Natural Products' dividend yield is 0.89% at the previous close: dividends of ₹0.80 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹89.57. They were ₹0.45 on 10 August 2026 and ₹0.35 on 18 February 2026 (interim).
On 30 September 2026, AVT Natural Products' shares were held by promoters 75.00%, foreign portfolio investors (FII/FPI) 0.04%, domestic institutions (DII) 0.02% (including mutual funds at 0.00%) and retail and other non-institutional investors 24.95%. Over the year, FII holding was down 0.02 percentage points from 0.06% and DII holding was down 0.21 percentage points from 0.23%.
Promoters held 75.00% of AVT Natural Products on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
In FY26, AVT Natural Products generated ₹12 crore of cash from operations and spent ₹23.4 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹11.4 crore. In FY25 it was −₹41.7 crore.
AVT Natural Products has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
AVT Natural Products' latest results are for Q1 FY27 (April–June 2026), filed on 14 August 2026: consolidated net profit ₹31.1 crore, up 156.7% from ₹12.1 crore in Q1 FY26; revenue from operations ₹241 crore, up 82.2% year on year.
In FY26 (April 2025–March 2026), AVT Natural Products' consolidated net profit was ₹64.8 crore, up 34.4% from ₹48.2 crore in FY25, on revenue from operations of ₹713 crore (up 28.3%). Over three years, from FY23, net profit was down 16.3%.
In FY26, AVT Natural Products earned net profit of ₹64.8 crore on revenue of ₹713 crore, against ₹115 crore on ₹1,440 crore for Chaman Lal Setia Exports. AVT Natural Products' operating margin was 11.0% (Chaman Lal Setia Exports 10.6%) and its return on equity 12.2% (Chaman Lal Setia Exports 14.6%).
On FY26 consolidated figures, against Chaman Lal Setia Exports and Bombay Super Hybrid Seeds: AVT Natural Products' operating margin of 11.0% is the highest of the three (Chaman Lal Setia Exports 10.6%, Bombay Super Hybrid Seeds 9.9%; peer average 10.2%); its return on equity of 12.2% is the lowest of the three (Chaman Lal Setia Exports 14.6%, Bombay Super Hybrid Seeds 22.7%; peer average 18.6%); its revenue growth over three years of 7.0% a year is the second highest of the three (Chaman Lal Setia Exports 1.2% a year, Bombay Super Hybrid Seeds 14.7% a year; peer average 8.0% a year).
From AVT Natural Products' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.